Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shengtai Pharma to Seek Growth in International Sales

publication date: Oct 30, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shengtai Pharmaceutical will begin a push to sell its pharmaceutical grade glucose products internationally. To get this done, the company has restructured its international sales team. The company said it already has customers in 70 countries, but according to SEC documents, Shengtai realized just 17% of its pharmaceutical product revenues from foreign countries in fiscal 2008 (ended June 30). Shengtai has added its capacity to produce pharmaceutical grade glucose, raising its annual product capability by 120,000 tons to approximately 180,000 tons. More details...

Stock Symbol: (OTCBB: SGTI)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors